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coronary heart disease, diabetes, hyperlipidemia, smoking and
drinking to the inﬂuence factors of ventricular instantly pacing
threshold; Women, age, diabetes, alcohol as the inﬂuence factors of
ventricular 5-10 minutes pacing threshold; Coronary heart disease,
smoking as the inﬂuence factors of atrial pacing immediately
threshold;Diabetes, smoking,5-10 minutes for atrial pacing threshold
of inﬂuencing factors.
2. Different time of myocardial enzyme levels. MYO difference of
preoperative and postoperative different time have statistically sig-
niﬁcance (F¼36.196, P<0.001);CK difference of preoperative and
postoperative different time is statistically signiﬁcant (F¼39.075,
P<0.001);CK – MB difference of preoperative and postoperative
different time is statistically signiﬁcant (F¼11.469, P<0.001);LDH
difference of preoperative and postoperative different time is statis-
tically signiﬁcant (F¼25.430). CTnI concentration pacemaker preop-
erative and postoperative different time difference had statistical
signiﬁcance (F¼21.456, P<21.456).
3. Myocardial enzyme levels, different groups are compared The
myocardial enzyme concentration comparing differences between
single and two pacing leads group had no statistical signiﬁcance.
CONCLUSIONS This study shows that: female, age, smoking, drink-
ing, coronary heart disease, diabetes, hyperlipidemia, heart pace-
makers is active ﬁxed pacing lead in the short term after implantation
of pacing threshold values of independent factors. Myocardial enzyme
level differences of active pacing leads planted before and in different
time after operation were statistically signiﬁcant. There was no sta-
tistically signiﬁcant difference of myocardial enzyme levels implanted
active ﬁxed pacing lead between single and two leads group (P > 0.05).
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OBJECTIVES To assess the efﬁcacy and safety of low-dose b-blocker
for the treatment of three types of vasovagal syncope.
METHODS Sixty-eight consecutive patients (23 males and45 fema-
les;age 3612y) with vasovagal syncope conﬁrmed by head upright tilt
testing (HUTT) from June, 2010 to September, 2014 were enrolled,
including 18 patients of vasodepressive type (VD), 21 patients of car-
dioinhibitory type (CI), and 29 patients of mixed type. Oral b-blocker
with a dosage of 23.75 mg/day was given to each patients. The fre-
quency of syncope, negative conversion rate of HUTT, and potential
adverse reactions (heart50bpm, blood pressure85/60mmHg, or
obviously weakness) were recorded at the follow-up of 1, 3, 6 and 12
months. The efﬁcacy of treatment is deﬁned as either a  50%
reduction of syncope attacks or a negative conversion of HUTT.
RESULTS For all patients, the effective rates signiﬁcantly increased
alongwith the follow-up time (30.88% vs. 42.65% vs. 64.71% vs. 69.12%
at 1, 3, 6 and 12 months respectively, p<0.05). At the 1st month follow-
up, there was no signiﬁcant difference of the effective rates among
three types of vasovagal syncope (27.77% vs. 33.33% vs. 31.03%,
p>0.05). However, CI patients had higher effective rates than VD and
mixed patients at the follow-up of 3 months (52.38% vs. 44.44% vs.
34.48% respectively, p<0.05), 6 months ( 76.19% vs. 61.11% vs. 58.62%
respectively, p<0.01) and 12 months (85.71% vs. 61.11% vs. 62.07%
respectively, p<0.01). No adverse reactionwas recorded for all patients.
CONCLUSIONS Low-dose b-blocker is effective and safe for the
treatment of vasovagal syncope. Compared to VD and mixed patients,
CI patients seem to get more beneﬁts from a long-term treatment due
to the differences of pathogenesis.
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OBJECTIVES To summarize the experience and outcomes of radio-
frequency catheter ablation (RFCA) of accessory pathways connecting
the right atrial appendage (RAA) and right ventricle (RV) in our center.METHODS We reviewed all the adult (14 years) 489 cases of supra-
ventricular tachycardia due to accessory pathways (AP) from Jan 2011
to Dec 2013. Two patients were diagnosed to have APs connecting the
RAA and RV through electrophysiological study (EPS) and accepted
RFCA in 2011. We reviewed their surface ECGs and EPS courses, and
summarized their electrophysiological features.
RESULTS The 2 patients were 17 years old (female) and 20years old
(male), respectively. One patient had received a failed RFCA proce-
dure in another center before he was referred to us. None of them
suffered syncope and pre-syncope before EPS. Both patients had a
type B WPW pattern of surface ECG with positive delta waves in lead I,
avL and V1. One patient’s delta wave in inferior leads (II, III, avF) were
positive. The other patient’s delta wave were positive in lead II and
avF, while ﬂat in lead III. Their EPS conﬁrmed that the APs located on
the right side. We failed to eliminate the delta waves and V-A con-
ductions via APs on the earliest A wave on the tricuspid annuli (TA) at
the ﬁrst attempts. We then mapped diffusely in the right atria and got
the earliest retrograde A waves in the RAA, one on the lower portion of
RAA free wall with small V wave (V/A<1), the other on the higher
portion of RAA base with barely visible V wave. RFCA broke the APs
successfully in the RAAs. Both patients have remained symptomless
after RFCA in our center with normal surface ECG pattern.
CONCLUSIONS The atrial end of APs can exist in other than the atrio-
ventricular annulus, such as RAA, which makes ablation challenging.
RFCA can cure these patients successfully with exquisite mapping.
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OBJECTIVES Catecholaminergic polymorphic ventricular tachycardia
(CPVT) is a rare lethal disorder among inherited arrhythmogenic
channelopathies, and would be misdiagnosed by neurologists for the
analogous symptom of syncope. We aim to describe a long-term
misdiagnosis case of CPVT as epilepsy caused by ryanodine receptor 2
gene (RyR2) mutation.
METHODS Clinical data of the patient was collected and analyzed, and
the candidate gene screening was performed by direct sequencing.
RESULTS An 11-year-old male presented with syncope accompanied
with paroxysmal convulsion mainly induced by excise since age 3. He
was diagnosed with epilepsy in several local hospital, but had poor
therapeutic effect of antiepileptic drugs and surgery. When he was
admitted to our hospital, a series of heart-related clinical examina-
tions were performed and showed negative. The electroencephalo-
gram revealed unspeciﬁc as well. However, the bidirectional and
polymorphic ventricular tachycardia was captured via exercise testing
and a RyR2 gene mutation (c.7202G>A, p.R2401H) was identiﬁed by
genetic testing. After taking a high dose of b-adrenergic blocker
(metoprolol succinate sustained-release tablet), the patient has been
free from attacks of syncope for 1 year of follow-up.
CONCLUSIONS The phenotype of syncope together with multiple
ventricular arrhythmias on exercise ECG and a RyR2 mutation sug-
gested that the boy suffers from CPVT. CPVT might be difﬁcult to
distinguish from epilepsy due to the normal heart structure and
resting electrocardiogram of patients, especially for neurologists
knowing less about the disease. Speciﬁc electrocardiographic and
genetic testing should be considered for early diagnosis and treatment
to the prevention of sudden death.
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OBJECTIVES To evaluate left ventricular systolic synchronization
during permanent direct His Bundle pacing.
METHODS A total of 42 patients who met class I or class IIa indications
for device-based therapy of cardiac rhythm abnormalities were
enrolled and randomly assigned to perform either direct His Bundle
pacing (DHBP) or right ventricular apical pacing (RVA). A quadrupolar
electrophysiology catheter was advanced to locate His bundle and a
